Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin

M Hu, B Tomlinson - Expert opinion on drug metabolism & …, 2014 - Taylor & Francis
Introduction: Statins are the cornerstone of lipid-lowering therapy to reduce the risk of
coronary heart disease. Rosuvastatin and pitavastatin are the two recently developed statins …

Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin.

M Hu, B Tomlinson - Expert Opinion on Drug Metabolism & …, 2013 - europepmc.org
Evaluation of the pharmacokinetics and drug interactions of the two recently developed
statins, rosuvastatin and pitavastatin. - Abstract - Europe PMC Sign in | Create an account …

[引用][C] Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin

M Hu, B Tomlinson - Expert Opinion on Drug Metabolism & Toxicology, 2013 - cir.nii.ac.jp
Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins,
rosuvastatin and pitavastatin | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin

M Hu, B Tomlinson - Expert opinion on drug metabolism …, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction Statins are the cornerstone of lipid-lowering therapy to reduce the risk of
coronary heart disease. Rosuvastatin and pitavastatin are the two recently developed statins …